GLP-1 drugs like (Ozempic and Wegovy) have finally started to make weight loss a sustainable reality for many people with ...

March 9 (Reuters) - Eli Lilly said on Monday a small number of basic Medicare drug plans may not follow the $50 per month cap ...

After years of fighting over compounded weight loss drugs, Hims & Hers and Novo Nordisk are teaming up to sell Ozempic and Wegovy — a shift that could raise costs for patients.

GLP-1 agonist market expected to grow from $70B in 2025 to $201B in 20301Proprietary Forzet formulation provides ...

AI-powered community platform highlights the role of daily nutrition habits and peer accountability in long-term ...

A new study suggests that widely used GLP-1 weight-loss drugs may do more than improve metabolic health: they could also protect the heart after a heart attack. Doctors can often reopen the blocked ...

Hansoh’s olatorepatide achieved 19% weight loss at 48 weeks in a Phase 3 trial in China, handing partner Regeneron a glimmer ...

A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this ...

During hibernation, brown bears spend up to six months lying almost completely still, without eating, drinking or exercising.